Next Article in Journal
Wspomnienie o prof. Stanisławie Filipeckim (1927–2007)
Previous Article in Journal
Role of Ciclesonide in Asthma Therapy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 76
Issue 1
10.5603/ARM.27928
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Guidelines

Systemic Treatment of Non-small Cell Lung Cancer—Recommendations Based on the Results of Reliable Clinical Trials

by
Jacek Jassem
*,
Kazimierz Drosik
,
Rafał Dziadziuszko
,
Radzisław Kordek
,
Jerzy Kozielski
,
Dariusz Kowalski
,
Maciej Krzakowski
,
Jacek Nikliński
,
Włodzimierz Olszewski
,
Tadeusz Orłowski
,
Rodryg Ramlau
and
Kazimierz Roszkowski-Śliż
Wydawcą Serwisu Jest “Via Medica sp. z o.o.” sp.k., ul. Świętokrzyska 73, 80-180 Gdańsk, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2008, 76(1), 44-52; https://doi.org/10.5603/ARM.27928
Submission received: 14 December 2007 / Revised: 14 December 2007 / Accepted: 14 December 2007 / Published: 14 December 2007

Abstract

Lung cancer is in Poland the most common malignancy. Non-small cell lung cancer (NSCLC) accounts for approximately 80% of all lung tumors. In the multidisciplinary treatment of non-small cell lung cancer patients the role of chemotherapy and, most recently, molecular targeted therapy is increasing. In 2005 we published recommendations for systemic treatment of non-small cell lung cancer and mesothelioma. As many new studies have been published since, it was necessary to update this document. We present here a consensus statement on this topic, prepared by a panel of experts in oncology, thoracic surgery, pathology and pneumonology.

Share and Cite

MDPI and ACS Style

Jassem, J.; Drosik, K.; Dziadziuszko, R.; Kordek, R.; Kozielski, J.; Kowalski, D.; Krzakowski, M.; Nikliński, J.; Olszewski, W.; Orłowski, T.; et al. Systemic Treatment of Non-small Cell Lung Cancer—Recommendations Based on the Results of Reliable Clinical Trials. Adv. Respir. Med. 2008, 76, 44-52. https://doi.org/10.5603/ARM.27928

AMA Style

Jassem J, Drosik K, Dziadziuszko R, Kordek R, Kozielski J, Kowalski D, Krzakowski M, Nikliński J, Olszewski W, Orłowski T, et al. Systemic Treatment of Non-small Cell Lung Cancer—Recommendations Based on the Results of Reliable Clinical Trials. Advances in Respiratory Medicine. 2008; 76(1):44-52. https://doi.org/10.5603/ARM.27928

Chicago/Turabian Style

Jassem, Jacek, Kazimierz Drosik, Rafał Dziadziuszko, Radzisław Kordek, Jerzy Kozielski, Dariusz Kowalski, Maciej Krzakowski, Jacek Nikliński, Włodzimierz Olszewski, Tadeusz Orłowski, and et al. 2008. "Systemic Treatment of Non-small Cell Lung Cancer—Recommendations Based on the Results of Reliable Clinical Trials" Advances in Respiratory Medicine 76, no. 1: 44-52. https://doi.org/10.5603/ARM.27928

Article Metrics

Back to TopTop